Qingdao Haier Biomedical Hits Day Low at CNY 31.86 Amid Price Pressure

Qingdao Haier Biomedical Co., Ltd. experienced a significant decline today, with the stock dropping by 5.44% and reaching an intraday low of CNY 31.86. This performance stands in contrast to the China Shanghai Composite, which saw a slight increase of 0.12% on the same day. Over the past week, Qingdao Haier Biomedical has faced a 3.1% decrease, while its monthly performance reflects a decline of 2.37%. Year-to-date, the stock has managed a modest gain of 1.23%, but this is overshadowed by a substantial 47.67% drop over the past three years and a staggering 67.11% decline over the last five years. Financial metrics indicate ongoing challenges for the company, with a net profit of CNY 86.33 million reflecting a significant decrease of 49.8%. The return on capital employed (ROCE) stands at a low 5.93%, further highlighting the company's struggles. Despite a dividend yield of 1.38%, the stock has consistently underperformed against the benchmark, raising concerns about its long-term growth prospects in the industrial manufacturing sector.